Dr. Patricia Kern Di Scala Andreis | Dentistry| Excellence in Academia Award

Published on by Global Academic Awards

Dr. Patricia Kern Di Scala Andreis | Dentistry| Excellence in Academia Award

PhD student, Pontificia Universidade Católica do Paraná, Brazil

Dr. Patricia Kern Di Andreis, an accomplished orthodontist from Paraguay, is the proprietor of KERN Odontologia. With expertise in various dental specialties, she is known for her passion for improving patients’ oral health. Dr. Kern is actively engaged in clinical research and dental education, blending her technical skills with a focus on innovation and patient care. 🌟🦷

Publication Profile

ORCID

Strengths for the Award:

  1. Diverse Expertise: Dr. Patricia Kern Di Andreis has extensive qualifications across various fields within dentistry, including orthodontics, implantology, dentistic restorations, and orofacial harmonization. This interdisciplinary expertise showcases her commitment to both clinical excellence and continuous learning, key traits for the Research for Excellence in Academia Award.
  2. Research Contributions: Her work includes impactful publications, such as “Predicting the Risk of Maxillary Canine Impaction Using Supervised Machine Learning” and studies on bruxism and facial pain during the COVID-19 pandemic. These publications demonstrate her ability to address both contemporary issues and long-standing clinical challenges through innovative research.
  3. Leadership and Service: Her roles as a proprietor of multiple dental clinics and her involvement as treasurer in the Asociación de los Jovenes Empresarios Paraguay highlight her leadership and contributions to the dental community, especially in Paraguay. Her service to dental associations in Paraguay and Brazil reflects her commitment to the profession on a broader scale.
  4. Teaching and Mentorship: Dr. Kern has academic credentials in university didactics, positioning her as an educator in the field. Her experience in integrating orthodontic knowledge with teaching demonstrates her contribution to shaping future professionals in the field.

Areas for Improvement:

  1. International Recognition: While Dr. Kern’s work is widely recognized in Latin America, increasing her visibility and collaboration on the global stage would further bolster her candidacy for an award of this scale. Participation in international conferences and broader collaboration might elevate her profile.
  2. Expansion of Research Impact: While her publications cover important areas in dentistry, expanding her research to include more interdisciplinary work or larger clinical trials could enhance the overall impact of her academic contributions.
  3. Higher Education Degrees: Dr. Kern is currently a master’s candidate, and while her specialization in orthodontics and related areas is strong, obtaining a PhD or equivalent higher research degree could enhance her academic stature and research credentials.

Education

Dr. Kern holds a rich educational background in dentistry. She is currently pursuing a Master’s in Integrated Clinical Dentistry with an emphasis on Orthodontics from Pontificia Universidade Católica do Paraná. Additionally, she has specialized qualifications in Orofacial Harmonization, Implantology, Orthodontics, Restorative Dentistry, and Temporomandibular Joint Dysfunction. 🎓📚

Experience

Dr. Kern has over a decade of experience running her own dental practice, with previous positions in both Paraguay and Brazil. She currently leads KERN Odontologia as the Technical Director, offering a range of dental services while maintaining her role as a trusted expert in orthodontics. 💼🔬

Research Focus

Dr. Kern’s research focuses on advanced orthodontic techniques, facial pain management, and the impact of dental treatments on patients’ overall well-being. She is particularly interested in bruxism, occlusal splints, and early orthodontic interventions in special needs patients. 🔍📈

Awards and Honors

Dr. Kern has earned recognition for her dedication to dentistry, including her role as Treasurer for the Asociación de los Jovenes Empresarios Paraguay. She is a proud member of professional organizations such as the Circulo de Odontólogos del Paraguay and the Conselho Regional De Odontologia do Paraná. 🏆👩‍⚕️

Publication Top Notes

Dr. Kern has published extensively in international journals, contributing valuable insights to the field of orthodontics and dental health. Her works include studies on maxillary canine impaction using machine learning and the efficiency of occlusal stabilization splints, with articles frequently cited by peers in the field. ✍️📖

“Predicting the Risk of Maxillary Canine Impaction Based on Maxillary Measurements Using Supervised Machine Learning” – Orthodontics & Craniofacial Research, 2024 DOI: 10.1111/ocr.12863

“Efficiency of mixed and rigid occlusal stabilization splints: Randomized clinical trial” – Brazilian Oral Research, 2024 DOI: 10.1590/1807-3107bor-2024.vol38.0017

“Impact of the COVID-19 pandemic on facial pain, anxiety, depression, quality of life, and awake bruxism in sleep bruxism patients, occlusal splint users” – Brazilian Journal of Implantology and Health Sciences, 2023 DOI: 10.36557/2674-8169.2023v5n5p202-22

Conclusion:

Dr. Patricia Kern Di Andreis has demonstrated excellence in both clinical practice and academic research, making her a strong candidate for the Research for Excellence in Academia Award. Her qualifications, service, and innovative research showcase her contributions to the dental field. However, further global engagement and advanced research degrees could strengthen her profile even more for future academic recognition.

Min-ran Li | Medicine and Dentistry | Women Researcher Award

Published on by Global Academic Awards

Ms. Min-ran Li | Medicine and Dentistry | Women Researcher Award

Ms. Min-ran Li, The First Affiliated Hospital of Jinan University, China

Dr. Minran Li is the Chief Physician at the Division of Infectious Disease at The First Affiliated Hospital of Jinan University. He earned his M.D. in Internal Medicine from Peking University and has extensive expertise in infectious diseases, particularly nonalcoholic steatohepatitis (NASH) and chronic hepatitis B. His research focuses on discovering noninvasive biomarkers and the molecular mechanisms behind liver diseases. Dr. Li has published numerous articles and has been recognized as a Guangdong High-Level Personnel of Young Talents. 🏥📚

Publication Profile

Scopus

 

Education

Ms. Li holds an M.D. in Internal Medicine (Infectious Disease) from Beijing Peking University, a Master’s in Internal Medicine from Hebei Medical University, and a Bachelor’s in Clinical Medicine. This strong educational foundation has empowered her expertise in infectious diseases, particularly liver-related conditions like NASH (nonalcoholic steatohepatitis) and CHB (chronic hepatitis B).

Work Experience

Currently serving as Chief Physician in the Division of Infectious Diseases at the First Affiliated Hospital of Jinan University, Ms. Li has progressively taken on roles of increasing responsibility, including as Associate Chief Physician at The Fifth Hospital of Shijiazhuang. Her work centers on managing liver diseases and exploring innovative biomarkers.

Research Interests

Her research focuses on discovering noninvasive biomarkers for pathological features of NASH in combination with CHB. Her findings on the role of HIGD1A and fibrosis development in liver disease have been pivotal in identifying therapeutic targets, advancing the understanding of liver disease progression.

Awards and Recognitions

Her dedication has been recognized with honors such as the Guangdong High-Level Personnel of Young Talents Program and the Yangcheng Good Doctor Award, underscoring her excellence in medical research and practice.

Conclusion

Ms. Min-ran Li’s strong academic background, leadership in liver disease research, and national and international recognition make her a strong candidate for the Research for Women Researcher Award.

 

Publication Top Notes

  • Pan, Y. et al. (2024). Overexpression of LAG-3: a potential indicator of low immune function in tuberculosis. Frontiers in Cellular and Infection Microbiology, 14, 1410015. 🦠 (0 citations)
  • Li, M.-R. et al. (2024). The function role of HIGD1A in nonalcoholic steatohepatitis from chronic hepatitis B. Scandinavian Journal of Gastroenterology, 59(4), 445–455. 🥗 (0 citations)
  • Li, J.-Z. et al. (2023). Mechanism and Progress of Natural Products in the Treatment of NAFLD-Related Fibrosis. Molecules, 28(23), 7936. 🌿 (0 citations)
  • Li, M.-R. et al. (2023). Clinical Features of Non-Alcoholic Fatty Liver Disease in the Non-Lean Population. Obesity Facts, 16(5), 427–434. 🍔 (1 citation)
  • Pan, Y. et al. (2023). Immune checkpoint inhibitors in cancer patients with COVID-19. Open Life Sciences, 18(1), 20220641. 💉 (1 citation)
  • Li, J.-Z. et al. (2022). Characteristics and treatment strategies for hepatocellular carcinoma caused by nonalcoholic fatty liver disease. Zhonghua gan zang bing za zhi, 30(12), 1392–1396. 🏥 (0 citations)
  • Yang, L. et al. (2022). Progress in research of lipogenesis inhibitors for treatment of nonalcoholic fatty liver disease. World Chinese Journal of Digestology, 30(16), 735–742. 🧬 (1 citation)
  • Li, J.-Z. et al. (2021). The identify role and molecular mechanism of the MALAT1/hsa-mir-20b-5p/TXNIP axis in liver inflammation caused by CHB in patients with chronic HBV infection complicated with NAFLD. Virus Research, 298, 198405. 🔬 (20 citations)
  • Zheng, X.-L. et al. (2021). Effect of optimizing oxygen therapy on multiple organ function and prognosis of patients with COVID-19. Chinese Journal of Pathophysiology, 37(5), 909–914. 🫁 (0 citations)
  • Li, M.-R. et al. (2020). Clinical features of hepatitis B patients at immune-tolerance phase with basal core promoter and/or precore mutations. Journal of Viral Hepatitis, 27(10), 1044–1051. 🦠 (4 citations)

 

 

 

 

Rainer Pooth | Medicine and Dentistry Award | Best Innovation Award

Published on by Global Academic Awards

Dr. Rainer Pooth | Medicine and Dentistry Award | Best Innovation Award

Dr. Rainer Pooth, ICAAN GmbH, Germany

Based on the information provided, Dr. Rainer Pooth appears to be a highly suitable candidate for the “Research for Best Innovation Award” in the pharmaceutical and medical industry. Here’s an assessment of his qualifications:

Publication profile

Professional Experience & Leadership

Dr. Pooth has over 20 years of experience in the global pharmaceutical and medical industry, with a strong track record of leadership in multidisciplinary teams at both global and affiliate levels. His roles as Managing Director, Global Head of Medical/Scientific Affairs, and Head of Global Clinical Development demonstrate his ability to lead and innovate in complex, highly regulated environments. His strategic input in global R&D programs, project management, and regulatory affairs underscores his expertise in driving innovation and ensuring successful product development.

Achievements & Expertise

Dr. Pooth’s achievements include multiple approvals of medicinal products and medical devices across key global markets such as the EU, US, Australia, and Asia. He holds more than 35 patents, with a significant portion becoming commercially relevant, highlighting his innovative contributions to the field. His extensive publication record, including over 50 publications in international journals and books, as well as his role as an invited speaker at major scientific congresses, further cements his reputation as a leader in pharmaceutical research and innovation.

Global Impact & Collaboration

Dr. Pooth’s global network of experts and key opinion leaders, along with his experience in managing international submission teams and regulatory interactions, illustrates his ability to navigate and influence the global pharmaceutical landscape. His leadership in directing high-level global teams and managing collaborations with regulatory authorities and contract research organizations (CROs) demonstrates his capability to bring innovative products to market successfully.

Publication Top Notes

  • “Treatment of Refractory Cardiac Arrest by Controlled Reperfusion of the Whole Body” – A study exploring CARL in a multicenter setting, highlighting its impact on refractory cardiac arrest patients (2023).
  • “The Impact of Head Position on Neurological and Histopathological Outcome Following CARL” – Investigates how head positioning affects outcomes in a pig model during CARL (2023).
  • “Extracorporeal Cardiopulmonary Resuscitation—Evidence and Implications” – Discusses ECPR’s evidence base and its clinical implications (2023).
  • “Effects of Prolonged Serum Calcium Suppression during ECPR in Pigs” – Examines the effects of serum calcium suppression during ECPR, showing implications for treatment strategies (2023).
  • “Limiting Calcium Overload after Cardiac Arrest” – Focuses on the role of albumin in reducing calcium overload during CARL (2023).
  • “Pervasive Platelet Secretion Defects in SARS-CoV-2 Patients” – Analyzes platelet defects in COVID-19 patients and their potential implications for treatment (2023).
  • “CARL – Controlled Reperfusion of the Whole Body” – A book detailing the CARL procedure, providing a comprehensive resource for clinicians (2022).
  • “Observational Study on Implications of the COVID-19-Pandemic for Cardiopulmonary Resuscitation” – Examines the pandemic’s impact on resuscitation practices, offering valuable insights (2022).
  • “Monitoring Mitochondrial Partial Oxygen Pressure During Cardiac Arrest and ECPR” – A pilot study exploring mitochondrial oxygen monitoring during cardiac arrest in a pig model (2021).
  • “Brain Vulnerability and Viability after Ischaemia” – A review on the neurological outcomes following ischemic events, highlighting vulnerabilities and potential treatment avenues (2021).

Conclusion

Dr. Pooth’s extensive experience, significant contributions to the development and approval of innovative pharmaceutical products, and his leadership in global research and development make him a strong candidate for the “Research for Best Innovation Award.” His work has had a substantial impact on multiple therapeutic areas, including dermatology, immunology, aesthetic medicine, oncology, and neurology, making him well-deserving of recognition in this prestigious category.